MedTrace Logo

HIV and STIs Clinical Study in Germany

NCT03884816 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1017

Last updated 2022-11-29

No results posted yet for this study

Summary

The BRAHMS study is a prospective observational cohort study aiming to investigate how often people that are at risk to get infected with HIV contract HIV and how long people stay in the study. The University Hospital Essen is interested in finding out how often participants contact other sexually transmitted infections (STI) and hepatitis as well as in the development of HIV vaccines to test in the future. The University Hospital Essen will therefore also ask participants to fill out a questionnaire asking their general willingness to participate in such a trial (i.e., where the vaccine might be targeted to an HIV subtype not as common in Europe) to understand whether such testing would be possible in the future in Germany.

Conditions

  • HIV Infections
  • Sexual Behavior
  • Risk Reduction

Interventions

OTHER

Determine the Incidence and Retention Rate

Determine the incidence of HIV and the retention rate of MSM/TGW/TGM/Intersex at risk for HIV infection

Sponsors & Collaborators

  • US Military HIV Research Program

    collaborator NETWORK

  • United States Army Medical Materiel Development Activity

    collaborator FED

  • Federal Ministry of Health, Germany

    collaborator OTHER_GOV

  • German Center for Infection Research

    collaborator OTHER

  • Hendrik Streeck

    lead OTHER

Principal Investigators

  • Hendrik Streeck, Prof. Dr. · Institute for HIV Research

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2021-03-22
Completion
2021-03-22

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03884816 on ClinicalTrials.gov